Habermann TM - Search Results

1

Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.

Krull JE, Wenzl K, Hopper MA, Manske MK, Sarangi V, Maurer MJ, Larson MC, Mondello P, Yang Z, Novak JP, Serres M, Whitaker KR, Villasboas Bisneto JC, Habermann TM, Witzig TE, Link BK, Rimsza LM, King RL, Ansell SM, Cerhan JR, Novak AJ. Krull JE, et al. Among authors: habermann tm. Cell Rep Med. 2024 Mar 19;5(3):101443. doi: 10.1016/j.xcrm.2024.101443. Epub 2024 Feb 29. Cell Rep Med. 2024. PMID: 38428430 Free PMC article.

2

Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method.

Witzig TE, Banks PM, Stenson MJ, Griepp PR, Katzmann JA, Habermann TM, Colgan JP, Gonchoroff NJ. Witzig TE, et al. Among authors: habermann tm. Am J Clin Pathol. 1990 Sep;94(3):280-6. doi: 10.1093/ajcp/94.3.280. Am J Clin Pathol. 1990. PMID: 2204263

3

Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure.

Witzig TE, Gonchoroff NJ, Greipp PR, Katzmann JA, Stenson MJ, Habermann TM, Colgan JP, Therneau TM, Banks PM. Witzig TE, et al. Among authors: habermann tm. Am J Clin Pathol. 1989 Mar;91(3):298-301. doi: 10.1093/ajcp/91.3.298. Am J Clin Pathol. 1989. PMID: 2646907

4

Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies.

Greipp PR, Witzig TE, Gonchoroff NJ, Habermann TM, Katzmann JA, O'Fallon WM, Kyle RA. Greipp PR, et al. Among authors: habermann tm. Mayo Clin Proc. 1987 Nov;62(11):969-77. doi: 10.1016/s0025-6196(12)65066-6. Mayo Clin Proc. 1987. PMID: 3118117

5

S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.

Witzig TE, Habermann TM, Kurtin PJ, Schroeder G, Stenson MJ, Greipp PR. Witzig TE, et al. Among authors: habermann tm. Cancer. 1995 Sep 15;76(6):1059-64. doi: 10.1002/1097-0142(19950915)76:6<1059::aid-cncr2820760621>3.0.co;2-e. Cancer. 1995. PMID: 8625208

6

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.

Hartmann LC, Tschetter LK, Habermann TM, Ebbert LP, Johnson PS, Mailliard JA, Levitt R, Suman VJ, Witzig TE, Wieand HS, Miller LL, Moertel CG. Hartmann LC, et al. Among authors: habermann tm. N Engl J Med. 1997 Jun 19;336(25):1776-80. doi: 10.1056/NEJM199706193362502. N Engl J Med. 1997. PMID: 9187067 Free article. Clinical Trial.

7

Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.

Ansell SM, Habermann TM, Kurtin PJ, Witzig TE, Chen MG, Li CY, Inwards DJ, Colgan JP. Ansell SM, et al. Among authors: habermann tm. J Clin Oncol. 1997 Jun;15(6):2296-301. doi: 10.1200/JCO.1997.15.6.2296. J Clin Oncol. 1997. PMID: 9196143

8

Primary laryngeal lymphoma.

Ansell SM, Habermann TM, Hoyer JD, Strickler JG, Chen MG, McDonald TJ. Ansell SM, et al. Among authors: habermann tm. Laryngoscope. 1997 Nov;107(11 Pt 1):1502-6. doi: 10.1097/00005537-199711000-00014. Laryngoscope. 1997. PMID: 9369397

9

A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.

Witzig TE, Camoriano JK, Schroeder G, Kurtin PJ, Habermann TM. Witzig TE, et al. Among authors: habermann tm. Leuk Lymphoma. 1998 Jan;28(3-4):307-14. doi: 10.3109/10428199809092686. Leuk Lymphoma. 1998. PMID: 9517502 Clinical Trial.

10

Primary thyroid lymphoma.

Ansell SM, Grant CS, Habermann TM. Ansell SM, et al. Among authors: habermann tm. Semin Oncol. 1999 Jun;26(3):316-23. Semin Oncol. 1999. PMID: 10375088 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters